Champions Oncology, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for CSBR, updated each market day.
CSBR AI Sentiment
AI sees no strong directional signal for Champions Oncology, Inc. stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Champions Oncology, Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Sector
Exchange
Market Cap
$79,849,249
Cap Tier
Employees
306
Headquarters
BALTIMORE, MD
Listed Since
Oct. 31, 1994
CSBR Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CSBR Volatility
Champions Oncology, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
